The Global Liquid Biopsy Market in terms of revenue was estimated to be worth $4.3 billion in 2022 and is poised to reach $10.0 billion by 2027, growing at a CAGR of 18.3% from 2022 to 2027.
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |